(2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone

C22H26N6O3 — CID 154582158

IUPAC(2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone
SMILESCc1cc(C(=O)N2CCC3(CC2)Cn2nnc(COc4ccccc4)c2CO3)n(C)n1
InChIInChI=1S/C22H26N6O3/c1-16-12-19(26(2)24-16)21(29)27-10-8-22(9-11-27)15-28-20(14-31-22)18(23-25-28)13-30-17-6-4-3-5-7-17/h3-7,12H,8-11,13-15H2,1-2H3
InChIKeyUXMMLWMBQYLTTL-UHFFFAOYSA-N
MW422.49 g/mol
LogP2.10
Rot. Bonds4

About (2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone

(2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone (PubChem CID 154582158) has the molecular formula C22H26N6O3 and a molecular weight of 422.49 g/mol. Its IUPAC name is (2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone.

Molecular Properties

Compound Name(2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone
PubChem CID154582158
Molecular FormulaC22H26N6O3
Molecular Weight422.49 g/mol
Exact Mass422.21
IUPAC Name(2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone
SMILESCc1cc(C(=O)N2CCC3(CC2)Cn2nnc(COc4ccccc4)c2CO3)n(C)n1
InChIInChI=1S/C22H26N6O3/c1-16-12-19(26(2)24-16)21(29)27-10-8-22(9-11-27)15-28-20(14-31-22)18(23-25-28)13-30-17-6-4-3-5-7-17/h3-7,12H,8-11,13-15H2,1-2H3
InChIKeyUXMMLWMBQYLTTL-UHFFFAOYSA-N
XLogP2.10
TPSA87.30 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds4
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500422.49
LogP ≤ 52.10
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Analyze (2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone?
The IUPAC name of (2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone (CID 154582158) is (2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone.
What is the SMILES notation for (2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone?
The canonical SMILES for (2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone is Cc1cc(C(=O)N2CCC3(CC2)Cn2nnc(COc4ccccc4)c2CO3)n(C)n1.
What is the InChIKey of (2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone?
The InChIKey is UXMMLWMBQYLTTL-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H26N6O3/c1-16-12-19(26(2)24-16)21(29)27-10-8-22(9-11-27)15-28-20(14-31-22)18(23-25-28)13-30-17-6-4-3-5-7-17/h3-7,12H,8-11,13-15H2,1-2H3.
What are the key properties of (2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone?
(2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone has a molecular weight of 422.49 g/mol, XLogP of 2.10, 4 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (2,5-dimethylpyrazol-3-yl)-[3-(phenoxymethyl)spiro[4,7-dihydrotriazolo[5,1-c][1,4]oxazine-6,4'-piperidine]-1'-yl]methanone is sourced from PubChem (CID 154582158), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).